Precigen to announce first quarter 2024 financial results on may 14th and host a conference call on june 3rd following the late-breaking oral presentation for prgn-2012 at the 2024 asco annual meeting

Germantown, md. , may 8, 2024 /prnewswire/ -- precigen, inc. (nasdaq: pgen), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the company will report first quarter 2024 financial results after the market close on tuesday, may 14, 2024.
PGEN Ratings Summary
PGEN Quant Ranking